Welcome : Guest

Sanofi S.A. (France) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about Sanofi S.A., which is principally a Healthcare Company. Illustrated with 228 tables, the report showcases the company's recent news stories and events, sales performance, key markets and market position as against its competitors operating in the industry.

Code: PCP-00038
Price: $3500
Company Type: Public
Pages: 240
Date: January 2017
Market Data Tables: 228

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Table 1: Sanofi S.A’s Sales by Product Category Worldwide (2014-2015) in € Millions for Pharmaceuticals (Diabetes (Lantus®, Amaryl®, Apidra®, Toujeo®, Insuman®, Blood Glucose Monitoring (BGM), Lyxumia®, Afrezza®, and Other Diabetes Products), Oncology (Jevtana®, Thymoglobulin®, Eloxatin®, Taxotere®, Mozobil®, Zaltrap®, Other Oncology Products), Genzyme (Cerezyme®, Cerdelga®, Myozyme®/Lumizyme®, Fabrazyme®, Aldurazyme®, Other Rare Diseases Products, Aubagio®, and Lemtrada®), Established Prescription Products (Plavix®, Lovenox®, Renagel®/Renvela®, Aprovel®/CoAprovel®, Allegra®, Myslee®/Ambien®/ Stilnox®, Synvisc®/Synvisc-One®, Multaq®, Depakine®, Tritace®, Lasix®, Targocid®, Orudis®, Cordarone®, Xatral®, Actonel®, Auvi-Q®/Allerject®, and Other Prescription Products), Praluent® (Hypercholesterolemia), Consumer Health Care (Allegra®, Doliprane®, Essentiale®, Enterogermina®, Nasacort®, No Spa®, Lactacyd®, Maalox®, Dorflex®, Magné B6®, and Other Products), Generics), and Vaccines GBU (Polio/Pertussis/Hib Vaccines, Influenza Vaccines, Meningitis/Pneumonia Vaccines, Adult Booster Vaccines, Travel and Other Endemic Vaccines, Vaxserve, and Other Vaccines)......9
Table 2: Sanofi S.A’s Sales by Business Segment Worldwide (2014-2015) in Percentage for Pharmaceuticals (General Medicines & Emerging Markets GBU (Established Prescription Products, Consumer Health Care, Generics, Diabetes & Cardiovascular, Sanofi Genzyme), Sanofi Genzyme GBU (Oncology, Multiple Sclerosis, and Rare Diseases), and Diabetes & Cardiovascular GBU (Diabetes, and Cardiovascular)), and Vaccines GBU......10
Table 3: Sanofi S.A’s Sales by Geographic Region Worldwide (2014-2015) in Percentage for United States, Emerging Markets (Latin America, Asia (excluding South Asia), Africa, Middle-East and South Asia, and Eurasia and Other Emerging Markets), Western Europe, and Rest of the World (Japan, and Other Rest of the World)......11
Pharmaceuticals......14
Table 4: Pharma Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Injectables, Oral Solids, Tropicals and Others......14
Table 5: Pharmaceutical Market by Country Worldwide (2015) - Percentage Share Breakdown by Value for China, Japan, USA and Others......15
Table 6: Pharmaceuticals Market by Region Worldwide (2015) - Percentage Share Breakdown by Value Sales for Asia, Africa, and Australasia, European Union, Japan, Latin America, and North America......16
Table 7: Pharmaceuticals Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Generic, Originator Brand, and Others......17
Table 8: Pharmaceuticals Sales by Category Worldwide (2015) - Percentage Market Share Breakdown by Value for Active Pharmaceutical Ingredients, Contrast Products, Radiopharmaceuticals, and Specialty Pharmaceuticals......18
Table 9: Pharmaceuticals Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Biologics and Chemical Synthetic and Others......19
Table 10: New Pharmaceutical Licensed Drugs Market by Indication Worldwide (2015) - Percentage Share Breakdown by Value Sales for AIDS, Diabetes, Diabetes (DPP4), Hepatitis B, Hypertension, and Others......20
Table 11: New Pharmaceutical Licensed Drugs Market by Type Worldwide (2015) - Percentage Share Breakdown by Value Sales for Humulin, Trajenta, Truvada, Twynsta, Viread, and Others......21
Table 12: Emerging Market Pharma Sales by Country Worldwide (2015) - Percentage Share Breakdown by Value Sales for Africa & Middle East, Brazil, China, India, Russia, and Others......22
Table 13: Research & Development Spending in Pharmaceuticals by Category Worldwide (2015) - Percentage Market Share Breakdown by Value for Approval, Discovery, Pre-Clinical, Phase I, Phase II, Phase III, Phase IV, and Others......23
Table 14: Pharmaceutical Consumption by Category in Australia (2015) - Percentage Share Breakdown for Aged over 65 Years, and Aged under 65 Years......24
Table 15: Pharmaceutical Market by Region in Brazil (2015) - Percentage Share Breakdown by Value Sales for Mid-West, North, Northeast, São Paulo, South, and Others......25
Table 16: Pharmaceutical Sales by Category in Brazil (2015) - Percentage Share Breakdown by Value for Generics, Over the Counter (OTC) Drugs, and Prescription......26
Table 17: Pharmaceutical Market by Category in Canada (2015) - Percentage Share Breakdown by Value for Hospital and Retail......27
Table 18: Pharmaceutical Distribution Market by Region in China (2015) - Percentage Share Breakdown by Value for Eastern China, North East China, Northern China, Northwestern China, Southern China, and Southwestern China......28
Table 19: Pharmaceuticals Market by Therapeutic Area in China (2015) - Percentage Share Breakdown by Value Sales for Alimentary Tract and Metabolism, Blood and Blood Forming Organs, Cardiovascular Diseases, Musculo-Skeletal System, Nervous System, Oncology, Respiratory System, Systemic Anti- Infective, and Others......29
Table 20: Pharmaceutical Market by Country in Europe (2015) - Percentage Share Breakdown by Value Sales for France, Germany, Greece, Italy, Spain, UK, and Others......30
Table 21: Pharmaceutical Drugs Market by Category in Germany (2015) - Percentage Share Breakdown by Value Sales for Biopharmaceuticals, Pharma Drugs for Human Use, and Others......31
Table 22: Pharma Market by Category in Indonesia (2015) - Percentage Share Breakdown by Value for Branded Generics and Licensed, Over the Counter and Unbranded Generics......32
Table 23: Pharmaceutical Market by Region in Latin America (2015) - Percentage Share Breakdown by Value for Argentina, Brazil, Mexico, Venezuela and Others......33
Table 24: Retail Pharmaceutical Market by Type in Mexico (2015) - Percentage Share Breakdown by Value for Private Market and Public Market......34
Table 25: Spending on Pharmaceutical by Category in Nigeria (2015) - Percentage Share Breakdown by Value for Generic Drug Sales, Over-The-Counter Medicine Sales and Patented Drug Sales......35
Table 26: Private Pharmaceuticals Market by Segment in South Africa (2015) - Percentage Share Breakdown by Value for Branded and Ethical, Generic, Over the Counter and Others......36
Table 27: Pharmaceutical Drugs Manufacturers by Product Segment in the US (2015) - Percentage Share Breakdown by Value for Biological Products, Medicinal and Botanical Products, Oncological Products, and Others......37
Table 28: Speciality Pharmaceuticals Market by Category in the US (2015) - Percentage Share Breakdown by Value Sales for Anti-Coagulant, Growth Hormone, Hepatitis C, HIV/AIDS (incl oral solids), IVIG/Hemophilia, Macular Degeneration, Multiple Sclerosis, Oncology (incl. oral solids), Pulmonary Arterial Hypertension, Renal, Rheumatoid arthritis/Chrohn's, Transplant, and Others......38
Table 29: Pharmaceutical Market by Category in Vietnam (2015) - Percentage Share Breakdown by Value for Generic Drugs, Patented Drugs and Others......39
Diabetes......40
Table 30: Diabetes Market by Region Worldwide (2015) - Percentage Share Breakdown for Africa, Europe, Middle East & North Africa, North America & Caribbean, Southeast Asia, and Western Pacific......40
Table 31: Diabetes Market by Type Worldwide (2015) - Percentage Share Breakdown by Value for Insulin Type-1 Diabetes, Insulin Type-2 Diabetes, Dipeptidyl Peptidase 4, (DPP4), Glucagon-Like Peptide-1 (GLP-1), Dipeptidyl Peptidase 4, (DPP4) + Biguanide, and Others......41
Table 32: Diabetes Care Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Human Insulins, Modern Insulins, Victoza, and Others......42
Table 33: Type-II Diabetes Treatments Market Worldwide (2015-2020) in US$ Million......43
Table 34: Type II Diabetes Market by Treatment Worldwide (2015) - Percentage Share Breakdown by Value for DPP-IV Inhibitors, GLP-1 Agonists, SGLT-2 Inhibitors and Thiazolidinediones......44
Table 35: Type II Diabetes Market by Insulin Treatment Worldwide (2015) - Percentage Share Breakdown by Value for Diet and Exercise Only, Insulin and Orals and Insulin Only......45
Table 36: Diabetes Healthcare Market by Category in the US (2015) - Percentage Share Breakdown by Value for Anti -Diabetic Agents & Supplies, Doctor Office Visits, Hospital Care, Nursing/Residential Facility Stays, Prescription Medication, and Others......46
Table 37: Diabetes Market by Type in the US (2015) - Percentage Share Breakdown for Insulin Pumps, and Multiple Daily Injections......47
Table 38: Diabetes Market by Type in the US (2015) - Percentage Share Breakdown by Value for Type 1, and Type 2......48
Table 39: No. of Diabetes Patients by Medication in the US (2015) - Percentage Share Breakdown for Insulin and Oral Medication, Insulin Only, No Medication, and Oral Medication Only......49
Diabetes Drugs......50
Table 40: Diabetes Drug Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for DPP-4 Inhibitor, GK Activator, GLP-1 Agonist, GPCR Agonist, IL- Receptor Antagonist, Insulin Analogue, PPAR Agonist, SGLT-2 Inhibitor, and Others......50
Table 41: Diabetes/Metabolic Drugs Market by Category Worldwide (2015) - Percentage Breakdown by Value Sales for DPP-IV Inhibitors, Glitazones, GLP-1 Analogs, Insulins, Sulfonylureas, and Others......51
Table 42: Anti-Diabetic Drug Market by Treatment Class Worldwide (2015) - Percentage Share Breakdown by Value for Diet & Exercise, Incretion, Insulin and Oral Anti-Diabetic......52
Table 43: Antidiabetes Molecules Market by Drug Worldwide (2015) - Percentage Share Breakdown by Value for Metformin, Sulfonylureas, Thiazolidin Ediones and Others......53
Table 44: Anti-Diabetic Drugs Market in China (2015-2020) in RMB Million......54
Table 45: Diabetic Drugs Market by Category in China (2015) - Percentage Share Breakdown by Value for Biguanides, Glinide, Insulin, Sulfonylureas, α-glucosidase Inhibitor, and Others......55
Table 46: Anti-Diabetic Drugs Market by Category in China (2015) - Percentage Share Breakdown by Value for Insulin Drugs and Non-Insulin Drugs......56
Table 47: Diabetes Drugs Market by Product Category in China (2015) - Percentage Share Breakdown by Value for Acarbose, Insulin, Melbine, and Other Diabetes Drugs......57
Table 48: Diabetic Drugs Market by Category in the US (2015) - Percentage Share Breakdown by Value for DPP-IV & SGLT-2, GLP-1, Insulins, and Others......58
Table 49: Diabetic Drugs Market by Non-Insulin Therapy in the US (2015) - Percentage Share Breakdown by Volume for Biguanides, DPP-4 Inhibitor, Human GLP-1 Analogs, SGLT-2 Inhibitor, Sulfonylureas, and Others......59
Table 50: Oral Diabetes Medicine Market in the US (2015) - Percentage Share Breakdown by Value Sales for Dipeptidyl Peptidase-4 (DPP4), Metformin, Sulfonylureas, and Others......60
Non-Insulin Anti-Diabetic Drugs......61
Table 51: Non-Insulin Anti-Diabetic Drugs Market by Product in China (2015) - Percentage Share Breakdown by Value for Biguanides, Glucosidase Inhibitors, Nateglinide, Sulfonylurea and Others......61
Diabetic Macular Edema (DME)......62
Table 52: Diabetic Macular Edema (DME) Market by Drug Treatment Worldwide (2015) - Percentage Share Breakdown by Volume for Avastin, Laser Photocoagulation, Lucentis 0.3 mg, Steroids and Others......62
Table 53: Diabetic Macular Edema (DME) Anti Vascular Endothelial Growth Factor (VEGF) Market by Segment in the US (2015) - Percentage Share Breakdown by Volume for Avastin, Lucentis and Others......63
Insulin......64
Table 54: Insulin Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Aspart (Novolog), Detemir (Levemir), Glargine (Lantus), Glulisine (Apidra), Lispro (Humalog), and Rh Insulin......64
Table 55: Insulin Market by Type Worldwide (2015) - Percentage Share Breakdown by Value for Basal Insulins, Prandial Insulins and Pre-Mixed Insulin......65
Table 56: Insulin Market by Type Worldwide (2015) - Percentage Share Breakdown by Value for Fast Acting, Long Acting and Premix......66
Table 57: Insulin Market by Generation in China (2015) - Percentage Share Breakdown by Value for 1st Generation, 2nd Generation, and 3rd Generation......67
Table 58: Insulin Market by Product Type in the US (2015) - Percentage Share Breakdown by Value for Fast-Acting, Human, Long-Acting and Mix......68
DPP-4 Inhibitors......69
Table 59: DPP-4 Inhibitors Market by Product Category Worldwide (2015) - Percentage Share Breakdown by Value for Galvus & Galvumet (Novartis), Januvia & Janumet (MRK), Nesina & Kezano (Takeda), Onglyza & Kombiglyze (AZN/BMY) and Tradjenta & Jentadueto (BI/Lilly)......69
Table 60: DPP-4 Inhibitors Market in China (2015-2020) in RMB Million......70
Table 61: DPP-4 Inhibitors (Fixed Dose) Market by Product Category in Korea (2015) - Percentage Share Breakdown by Value for Galvusmet, Janumet, Janumet XR, Kombiglyze, Trajenta Duo and Zemimet......71
Table 62: DPP-4 Inhibitors (Non-fixed Dose) Market by Product Category in Korea (2015) - Percentage Share Breakdown by Value for Januvia, Nesina, Tradjenta, Zemiglo, and Others......72
Table 63: DPP-4 Inhibitors Market by Prescription in the US (2015) - Percentage Share Breakdown by Volume for Janumet (Sitagliptin + Metformin), Januvia (Sitagliptin), Kombiglyze XR (Saxagliptin + Metformin), Onglyza (Saxagliptin), and Others......73
Table 64: DPP-4 Inhibitors Market in the US (2015) in No. of Prescriptions......74
DPP-4 type Diabetes Drugs......75
Table 65: DPP-4 type Diabetes Drugs Market in Japan (2015) in Yen Million......75
Multiple Sclerosis......76
Table 66: Multiple Sclerosis Disease Occurrence by Type Worldwide (2015) - Percentage Breakdown by Volume for Begin MS, Primary Progressive MS, Relapsing-Remiting MS, and Secondary Progressive MS......76
Table 67: Multiple Sclerosis Patient Care Expenditure by Category Worldwide (2015) - Percentage Breakdown by Value for Adaptations, Ambulatory Care, Disease Modifying Drugs, Early Retirement, Hospital Inpatient Care, Informal Care, Prescription and OTC Drugs, Services, Sick-leave and Redused Working Time, and Tests......77
Table 68: Relapsing-Remitting Multiple Sclerosis (RRMS) Market by Region Worldwide (2015) - Percentage Share Breakdown by Volume for European Union (EU), US, Rest of World (RoW)......78
Table 69: No. of Tcelna (Imilecleucel-T) Secondary Progressive Multiple Sclerosis Patients by Category in the US (2015) - Percentage Breakdown for Primary Progressive MS Patients, Relapsing-Remitting MS Patients, and Secondary-Progressive MS Patients......79
Cold, Cough Remedies......80
Table 70: Cough-Cold Medication Market by Product in the US (2015) - Percentage Share Breakdown by Value for Anticholinergics, Antihistamines, Benzonatate, Expectorants, Triple Combinations and Others......80
Table 71: Cough-Cold Medication (Narcotics & Non-Norcotics) Market by Product in the US (2015) - Percentage Share Breakdown by Value for Benzonatate, Codeine, Dextromethorphan and Hydrocodone......81
Table 72: Cough and Cold Treatments Market through Supermarkets, Drug Stores, and Mass Merchandisers, (Including Wal-Mart), Military Commissaries and Select Club and Dollar Retail Chains by Type in the US (2015) - Percentage Share Breakdown by Value for Chest Rubs, Cold, Allergy, and Sinus Liquids, Cold, Allergy, and Sinus Tablets, Cough Drops, Cough Syrup, and Nasal Products......82
Table 73: Cold-Allergy-Sinus (Liquid and Powder) Market through Supermarkets, Drug Stores, Mass Merchandisers (Including Wal-Mart) in the US (2015) in US$ Million......83
Table 74: Cold-Allergy-Sinus Treatments (Liquid) Market through Supermarkets, Drug Stores, Mass Merchandisers (Including Wal-Mart), Military Commissaries and Select Club and Dollar Stores in the US (2015) in US$ Million......84
Table 75: Cold-Allergy-Sinus Treatments (Tablets and Packets) Market through Supermarkets, Drug Stores, Mass Merchandisers (Including Wal-Mart), Military Commissaries and Select Club and Dollar Stores in the US (2015) in US$ Million......85
Oncology Genomics......86
Table 76: Oncology Genomics Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Clinical, Hereditary, and Molecular Monitoring......86
Table 77: Oncology Genomics (Clinical, Hereditary, and Molecular Monitoring) Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for US, and Others......87
Table 78: Oncology Genomics Market by Category in the US (2015) - Percentage Share Breakdown by Value Sales for Clinical, Hereditary, and Molecular Monitoring......88
Consumer Health Market......89
Table 79: Consumer Health Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for Asia-Pacific, Latin America, North America, West European Union and Others......89
Table 80: Consumer Health Market in the US (2015) in US$ Million......90
Table 81: Consumer Healthcare Market by Segments in the US (2015) - Percentage Share Breakdown by Value for Analgesics, Animal Health, Antacids, Cough and Cold, Smoking Aids and Others......91
Vitamins and Dietary Supplements......92
Table 82: Vitamins and Supplements Market by Country Worldwide (2015) - Percentage Share Breakdown by Value Sales for China, European Union¸ Japan, USA and Others......92
Table 83: Vitamins and Supplements Retail Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Dietary Supplements, Paediatric Vitamins and Supplements, Tonics and Nutritive, and Vitamins......93
Table 84: Vitamins Market by Type Worldwide (2015) - Percentage Share Breakdown by Value for A, B, C, E, and Others......94
Table 85: Vitamins Sales by Category Worldwide (2015) - Percentage Share Breakdown by Value for Animal, and Human......95
Table 86: Vitamins and Dietary Supplements (VDS) Market by Category in the US (2015) - Percentage Share Breakdown by Value for Private-Label and Others......96
Table 87: Vitamin and Supplements Market by Channel in the US (2015) - Percentage Breakdown by Value for Mass Marketers, Specialty Retailers, and Others......97
Table 88: Vitamins Sales by Category through Supermarkets, Drug Stores and Mass Merchandisers (including Wal-Mart), Military Commissaries and Select Club and Dollar Stores in the US (2015) - Percentage Share Breakdown by Value for Adult Multivitamins, Calcium, Children's Multivitamins, Vitamin B, Vitamin C, Vitamins A&D, and Others......98
Table 89: Vitamins Sales through Supermarkets, Drug Stores, Mass Merchandisers (including Wal-Mart), Military Commissaries and Select Dollar and Club Chains by Sector in the US (2015) - Percentage Share Breakdown by Value for 1 & 2 Letter, Liquid Vitamins & Minerals, Mineral Supplements, and Multivitamins......99
Vaccines......100
Table 90: Vaccines Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Adult Prophylactic Vaccines (USD 8.5bn), Pediatric Vaccines (USD 16.7bn) and Others......100
Animal Health Market......101
Table 91: Animal Health Market by Region Worldwide (2015) - Percentage Share Breakdown by Value Sales for Asia-Pacific, Eastern Europe, Latin America, North America, Western Europe and Rest of World......101
Table 92: Animal Healthcare Market by Country Worldwide (2015) - Percentage Share Breakdown by Value Sales for Brazil, China, France, Germany, USA, and Others......102
Table 93: Animal Health Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Biologicals, Feed Additives and Pharmaceuticals......103
Table 94: Animal Health Market by Category Worldwide (2015) - Percentage Market Share Breakdown by Value Sales for Companion Animals, and Production Animals......104
Table 95: Animal Health Market by Species Worldwide (2015) - Percentage Share Breakdown by Value Sales for Cattle, Poultry, Sheep, Swine and Companion Animals......105
Table 96: Animal Healthcare Market by Product Type Worldwide (2015) - Percentage Share Breakdown by Value Sales for Anti-Infectives, Biologicals, Feed Additives, Parasiticides, and Others......106
Table 97: Animal Health Market by Therapeutic Class Worldwide (2015) - Percentage Share Breakdown by Value for Antibiotics and Therapeutic, Antiparasitic, Foot and Mouth Disease Vaccine, Supplements and Others......107
Table 98: Animal Health Market by Category in Brazil (2015) - Percentage Market Share Breakdown by Value Sales for Companion Animals, and Production Animals......108
Table 99: Animal Health Product Demand by Category in the US (2015) - Percentage Share Breakdown by Value for Companion Animals, Livestock and poultry, and Others......109
Pet Health Products......110
Table 100: Pet Health Products Market by Category in the US (2015) - Percentage Share Breakdown by Value for Diet Supplements, Parasiticides, Pharmaceuticals, Prescription Food, and Others......110
Diabetes Drugs......111
Table 101: Market Shares of Leading Diabetes Care Companies Worldwide (2014) - Percentage Breakdown by Value Sales for Bristol-Myers Squibb (Incl Amylin), Eli Lilly and Company, Merck & Co., Inc., Novo Nordisk A/S, Sanofi S.A. and Others......111
Table 102: Market Shares of Leading Diabetes Drugs Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for AstraZeneca Plc, Bristol-Myers Squibb Company, Eli Lilly and Company, GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Novo Nordisk A/S, Pfizer, Inc., Sanofi S.A., and Others......112
Table 103: Market Shares of Leading Anti-Diabetic Drug Manufacturers in India (2014) - Percentage Breakdown by Value for Abbott Healthcare Pvt Ltd., Biocon Limited, Lupin Pharmaceuticals, Inc., MSD Pharmaceuticals Private Limited, Sanofi-Aventis Groupe, Sun Pharmaceutical Industries Ltd., Wockhardt Ltd., and Others......113
Insulin......114
Table 104: Market Shares of Leading Insulin Companies Worldwide (2014) - Percentage Breakdown by Value Sales for Eli Lilly and Company, Novo Nordisk A/S, Sanofi S.A., and Others......114
Table 105: Market Shares of Leading Insulin Companies Worldwide (2014) - Percentage Breakdown by Volume Sales for Eli Lilly and Company, Novo Nordisk A/S, Sanofi S.A., and Others......115
Table 106: Market Shares of Leading Fast & Intermediate Type Insulin Producers Worldwide (2015) - Percentage Share Breakdown by Value for Eli Lilly and Company, Novo Nordisk, Sanofi S.A. and Others......116
Table 107: Market Shares of Leading Long-Acting Insulin Producing Companies Worldwide (2015) - Percentage Share Breakdown by Value for Sanofi S.A., Wockhardt Ltd., and Others......117
Table 108: Market Shares of Leading Insulin Companies in China (2014) - Percentage Share Breakdown by Value for Eli Lilly and Company, GanLee Pharmaceutical Co., Ltd., Novo Nordisk, Sanofi S.A., Shanghai Fosun Pharmaceutical Group Co., Ltd., United Laboratories International Holdings Ltd. (The), Tonghua Dongbao Pharmaceutical Co., Ltd., and Others......118
Table 109: Market Shares of Leading Insulin Companies in China (2015) - Percentage Share Breakdown by Volume for Novo Nordisk, Tonghua Dongbao Pharmaceutical Co., Ltd., Wanbang Biopharmaceuticals Co., Ltd. and Others......119
Table 110: Market Shares of Leading Insulin Companies in Europe (2014) - Percentage Breakdown by Volume Sales for Novo Nordisk A/S, and Others......120
Table 111: Market Shares of Leading Insulin Drug Manufacturers in India (2014) - Percentage Breakdown by Value for Biocon Ltd., Cadila Pharmaceuticals Ltd., Eli Lilly and Company India Pvt. Ltd., Lupin Pharmaceuticals, Inc., Novo Nordisk India Ltd., Pfizer India Ltd., Ranbaxy Laboratories Ltd., Sanofi India Ltd., Shreya Life Sciences Pvt. Ltd., USV Ltd., and Wockhardt Ltd.......121
Table 112: Market Shares of Leading Insulin Companies in Japan and Korea (2014) - Percentage Breakdown by Volume Sales for Novo Nordisk A/S, and Others......122
Table 113: Market Shares of Leading Insulin Companies in North America (2014) - Percentage Breakdown by Volume Sales for Novo Nordisk A/S, and Others......123
Table 114: Market Shares of Leading Private Pharmaceutical Companies in South Africa (2015) - Percentage Breakdown by Value for Adcock Ingram, Aspen Pharmacare Holdings Ltd., Cipla Ltd., Merck & Co., Inc., Novartis AG, Sanofi S.A., and Others......124
Second-Generation Insulin......125
Table 115: Market Shares of Leading Second-Generation Insulin Companies in China (2014) - Percentage Share Breakdown by Volume for Eli Lilly and Company, Novo Nordisk, The United Laboratories International Holdings, Ltd., and Tonghua Dongbao Pharmaceutical Co., Ltd.......125
Third-Generation Insulin......126
Table 116: Market Shares of Leading Third-Generation Insulin Companies in China (2014) - Percentage Share Breakdown by Volume for Eli Lilly and Company, Gan & Lee Pharmaceutical, Ltd., Novo Nordisk, and Sanofi S.A.......126
Human Insulin......127
Table 117: Market Shares of Leading Human Insulin Drug Manufacturers in India (2014) - Percentage Breakdown by Value for Biocon Limited, Eli Lilly and Company India Pvt. Ltd., Novo Nordisk India Limited, Sanofi India Limited, Wockhardt Ltd., and Others......127
DPP-4 Inhibitors......128
Table 118: Market Shares of Leading DPP-4 Inhibitors Manufacturers by Value Sales Worldwide (2015) - Percentage Share Breakdown for Merck & Co., Inc. (Januvia/Janumet), Novartis AG (Galvus/Galvumet) and Takeda Pharmaceutical Co., Ltd. (Nesina/Kezano), and Others......128
Table 119: Market Shares of Leading DPP-4 Inhibitors for Treatment of Diabetes in Japan (2015) - Percentage Share Breakdown by Value for Equa, Glactiv, Januvia, Nesina, and Others......129
Table 120: Market Shares of Leading DPP-4 Drug Brands in China (2015) - Percentage Share Breakdown by Value for Galvus, Januvia, Onglyza, and Others......130
Pharmaceuticals......131
Table 121: Market Shares of Leading Pharmaceutical Companies in Australia (2015) - Percentage Share Breakdown by Value for AstraZeneca, Pfizer, Inc. and Others......131
Table 122: Market Shares of Leading Pharmaceutical Distributors in Brazil (2015) - Percentage Share Breakdown by Value for Panpharma Participacoes S.A., Profarma Distribuidora de Produtos Farmaceuticos S.A., Santa Cruz and Others......132
Table 123: Market Shares of Leading Pharmaceutical Companies in Indonesia (2015) - Percentage Breakdown by Value Sales for Dexa Medica Group, PT Kalbe Farma Tbk., Pfizer Indonesia PT Tbk, Sanbe Farma PT, and Others......133
Table 124: Market Shares of Leading Pharmaceutical Suppliers to Hospitals in Indonesia (2015) - Percentage Breakdown by Value Sales for Dexa Medica Group, PT Kalbe Farma, Tbk, Sanbe Farma PT, Soho Group, and Others......134
Table 125: Market Shares of Leading Pharmaceutical Drugs Manufacturers in the US (2015) - Percentage Breakdown by Value for Amgen, Eli Lilly and Co., Johnson and Johnson Co, Merck & Co., Inc., Pfizer, Inc., and Others......135
Table 126: Market Shares of Leading Pharmaceutical Manufacturers by Value Sales in the US (2014) - Percentage Breakdown for Abbott Laboratories, Amgen Corporation, AstraZeneca Plc, Eli Lilly and Company, F. Hoffmann-La Roche AG, GlaxoSmithKline Plc, Johnson & Johnson, Merck & Co., Inc., Novartis International AG, Pfizer, Inc., Sanofi S.A., Teva Pharmaceutical Industries Ltd., and Others......136
Preclinical Pharmaceuticals......137
Table 127: Market Shares of Leading Preclinical Pharmaceutical Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Charles River Laboratories International, Inc. (CRL), Covance, Inc. (CVD), Pharmaceutical Product Development Inc. (PPDI), Wuxi Pharmatech (Cayman) Inc. (WX), and Others......137
Prescription Pharmaceuticals......138
Table 128: Market Shares of Leading Prescription Pharmaceutical Companies in Indonesia (2015) - Percentage Breakdown by Volume Sales for Dexa Medica Group, Interbat Pharmaceutical Industry PT, PT Kalbe Farma, Tbk, PT Sanbe Farma, and Others......138
Table 129: Market Shares of Leading RX Pharmaceutical Companies in Brazil (2014) - Percentage Breakdown by Value for Achelois Pharmaceuticals, Inc., Eurofarma Laboratórios, Hypermarcas S.A.,Pfizer, Inc., Roche AG, Sanofi - Medley Indústria Farmacêutica Ltda and Others......139
Table 130: Market Shares of Leading Prescription Pharmaceutical Companies in the US (2014) - Percentage Market Share Breakdown by Volume Sales for Actavis Plc, Amneal, Inc., Endo Pharma, Inc., Lupin Pharmaceuticals, Inc., Mylan Labs,Inc., Novartis International AG, Pfizer, Inc., Teva Pharmaceutical Industries Ltd., and Others......140
Table 131: Market Shares of Leading Prescription Drug Companies in the US (2014) - Percentage Breakdown by Value for Amgen, AstraZeneca Plc, Eli Lilly and Company, Genentech, Inc., GlaxoSmithKline plc, Johnson & Johnson, Ltd., Novartis International AG, Pfizer, Inc., Sanofi S.A., Teva Pharmaceutical Industries, Ltd., and Others......141
Table 132: Market Shares of Leading Prescription Drug Companies Spending through Media Ads in the US (2014) - Percentage Breakdown by Value for Amgen, AstraZeneca Plc, Eli Lilly and Company, Genentech, Inc., GlaxoSmithKline plc, Johnson & Johnson, Ltd., Novartis International AG, Pfizer, Inc., Sanofi S.A., and Others......142
RadioPharmaceuticals......143
Table 133: Market Shares of Leading Radiopharmaceutical Drug Providers in the US (2015) - Percentage Breakdown by Value for Amersham Plc, Cardinal Health, Inc., Independents, and Triad Healthcare Inc.......143
Generic Pharmaceuticals......144
Table 134: Global IV Generics Drug Market by Value Sales (2015) - Percentage Share Breakdown for Fresenius Kabi AG, Hospira, Inc., Mylan, Inc., Novartis International AG, Teva Pharmaceutical Industries Ltd., and Others......144
Table 135: Market Shares of Leading Generic Injectable Drug Manufacturers Worldwide (2015) - Percentage Breakdown by Volume for Baxter International, Inc., Fresenius SE & Co. KGaA, Hikma Pharmaceuticals Plc, Hospira, Inc., Novartis AG, Pfizer, Inc., Sagent Pharmaceuticals, Inc., Sanofi S.A., and Other......145
Table 136: Market Shares of Leading Generics Manufacturers in Australia (2015) - Percentage Share Breakdown by Value for Apotex, Inc., Aspen Pharmaceutical Holdings Ltd., Mylan, Inc., Sandoz and Others......146
Table 137: Market Shares of Leading Generics Pharmaceutical Companies in Brazil (2014) - Percentage Breakdown by Value for Achelois Pharmaceuticals, Inc., Ems Sigma Pharma Group, Eurofarma Laboratórios, Hypermarcas S.A., Pfizer, Inc., Sanofi - Medley Indústria Farmacêutica Ltda and Others......147
Table 138: Market Shares of Leading Branded Generic Pharmaceutical Companies in Brazil (2014) - Percentage Breakdown by Value for Cimed Indústria Farmacêutica Ltda, Ems Sigma Pharma Group, Hypermarcas S.A., Pfizer, Inc., Takeda Pharmaceutical Company Limited, União Química Farmacêutica Nacional S.A and Others......148
Table 139: Market Shares of Leading Generic Pharmaceutical Companies by Value Sales in India (2014) - Percentage Breakdown for Abbott India Ltd., Alkem Laboratories Ltd., Cipla Ltd., GlaxoSmithKline Pharmaceuticals Ltd. (GSK), Lupin Ltd., Mankind Pharma, Pfizer Ltd., Ranbaxy Laboratories Ltd., Sun Pharmaceutical Industries Ltd., Zydus Cadila and Others......149
Table 140: Market Shares of Leading Generics Manufacturers by Value Sales in South Africa (2014) - Percentage Breakdown for Adcock Ingram, Aspen Pharmacare Holdings Limited, Cipla Global Limited, Lupin Limited, Novartis International AG, Sanofi S.A., and Others......150
Table 141: Market Shares of Leading Generics Manufacturers in the US (2015) - Percentage Share Breakdown by Volume for Actavis plc, Mylan N.V., Sandoz, Teva Pharmaceutical Industries Ltd. and Others......151
Table 142: Market Shares of Leading Generics Manufacturers in the US (2015) - Percentage Share Breakdown by Value for Apotex, Inc., Dr. Reddy’s Laboratories Ltd. and GlaxoSmithKline......152
Table 143: Market Shares of Leading Derma Generics Manufacturers in the US (2015) - Percentage Share Breakdown by Value for Actavis plc, Perrigo Company plc, Sandoz, Taro Pharmaceutical Industries Ltd. and Others......153
Table 144: Market Shares of Leading Non-Branded Generics Manufacturers in the US (2015) - Percentage Share Breakdown by Value for Actavis, Mylan N.V., Teva Pharmaceutical Industries Ltd. and Others......154
Table 145: Market Shares of Leading Generic Injectable Drug Manufacturers in the US (2015) - Percentage Share Breakdown by Value for Baxter International, Inc., Fresenius, Hospira, Inc., Novartis (Sandoz), and Others......155
Multiple Sclerosis......156
Table 146: Market Shares of Leading Multiple Sclerosis Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for Biogen Idec, Novartis AG, Sanofi S.A., and Others......156
Table 147: Market Shares of Leading Drug Brands for Relapsing-Remitting Multiple Sclerosis (RRMS) Worldwide (2015) - Percentage Breakdown by No. of Patients for Avonex, Betaseron, Copaxone, Gilenya, Laquinimod, Rebif, Tysabri, and Others......157
Table 148: Market Shares of Leading Drug Brands for Relapsing-Remitting Multiple Sclerosis (RRMS) Worldwide (2015) - Percentage Breakdown by Value for Avonex, Betaseron, Copaxone, Gilenya, Laquinimod, Rebif, Tysabri, and Others......158
Gaucher Disease Drugs......159
Table 149: Market Shares of Drugs for Gaucher Disease by Region Worldwide (2014) - Percentage Breakdown by Value for European Union, United States and Rest of World......159
Table 150: Market Shares of Leading Drugs for Gaucher Disease Worldwide (2014) - Percentage Breakdown by Value for Cerezyme and Velaglucerase Alfa......160
Table 151: Market Shares of Leading Drugs for Gaucher Disease in Brazil (2015) - Percentage Share Breakdown by Value for Cerezyme, Eliglustat and Others......161
Table 152: Market Shares of Leading Drugs for Gaucher Disease in EU (2014) - Percentage Breakdown by Value for Cerezyme and Velaglucerase Alfa......162
Table 153: Market Shares of Leading Drugs for Gaucher Disease in the US (2014) - Percentage Breakdown by Value for Cerezyme and Velaglucerase Alfa......163
Cold, Cough Remedies......164
Table 154: Market Shares of Leading Cough & Cold Medicine Manufacturers for OTC Worldwide (2015) - Percentage Share Breakdown by Value for Johnson & Johnson, Procter & Gamble Co., and Others......164
Table 155: Market Shares of Leading Manufacturers for Cough and Cold Remedies Worldwide (2015) - Percentage Breakdown by Value for Bayer AG, Johnson & Johnson, Pfizer, Inc., Procter & Gamble Co., Reckitt Benckiser Group Plc, Sanofi S.A., Private Label and Others......165
Table 156: Market Shares of Leading Cough, Cold Allergy Medicine Manufacturers Worldwide (2014) - Percentage Breakdown by Value Sales for Johnson & Johnson, Pfizer, Inc., Procter & Gamble Co., Reckitt Benckiser Plc, and Others......166
Table 157: Market Shares of Leading Cough & Cold Medicine Manufacturers for OTC in Africa Middle East (2015) - Percentage Share Breakdown by Value for GlaxoSmithKline, Johnson & Johnson and Others......167
Table 158: Market Shares of Leading Cough & Cold Medicine Manufacturers for OTC in Asia-Pacific (2015) - Percentage Share Breakdown by Value for Johnson & Johnson, Procter & Gamble Co., and Others......168
Table 159: Market Shares of Leading Cough & Cold Medicine Manufacturers for OTC in Europe (2015) - Percentage Share Breakdown by Value for GlaxoSmithKline, Johnson & Johnson, Procter & Gamble Co., and Others......169
Table 160: Market Shares of Leading Cold Remedies Brands in Indonesia (2015) - Percentage Share Breakdown by Value for Bodrex Flu Batuk, Decolgen, Mixagrip, Pro Cold, Ultra Flu and Others......170
Table 161: Market Shares of Leading Cold Remedies Brands in Indonesia (2015) - Percentage Share Breakdown by Volume for Bodrex Flu Batuk, Decolgen, Mixagrip, Pro Cold, Ultra Flu and Others......171
Table 162: Market Shares of Leading Cough & Cold Medicine Manufacturers for OTC in Latin America (2015) - Percentage Share Breakdown by Value for GlaxoSmithKline, Johnson & Johnson, Procter & Gamble Co., and Others......172
Table 163: Market Shares of Leading Cough & Cold Medicine Manufacturers for OTC in North America (2015) - Percentage Share Breakdown by Value for Johnson & Johnson, Procter & Gamble Co., and Others......173
Table 164: Market Shares of Leading Cough & Cold Medicine Manufacturers by Value Sales in the US (2015) - Percentage Share Breakdown for Procter & Gamble Co., and Others......174
Table 165: Market Shares of Leading Cough & Cold Medicine Manufacturers by Volume Sales in the US (2015) - Percentage Share Breakdown for Procter & Gamble Co., and Others......175
Table 166: Market Shares of Leading Cold, Allergy and Sinus (Liquid and Powder) Brands through Supermarkets, Drug Stores, and Mass Merchandisers, Military Commissaries and Select Club and Dollar Retail Chains in the US (2015) - Percentage Breakdown by Value for Children's Benadryl, Children's Dimetapp, Children's Mucinex, Mucinex Fast Max, Nasacort, Tylenol Cold, Vicks Dayquil, Vicks Nyquil, Vicks Nyquil and Dayquil, Private Label, and Others......176
Table 167: Market Shares of Leading Cold, Allergy and Sinus (Liquid) Brands through Supermarkets, Drug Stores, and Mass Merchandisers, (Including Wal-Mart), Military Commissaries and Select Club and Dollar Stores in the US (2015) - Percentage Breakdown by Value for Benadryl, Dimetapp, Mucinex, Mucinex Fast Max, Robitussin, Tylenol Cold, Tylenol Cold, Vicks Dayquil, Vicks Nyquil, Vicks Nyquil and Vicks Dayquil, Private Label, and Others......177
Table 168: Market Shares of Leading Cold, Allergy and Sinus Remedy (Tablet and Packet) Brands through Supermarkets, Drug Stores, and Mass Merchandisers, Military Commissaries and Select Club and Dollar Retail Chains in the US (2015) - Percentage Breakdown by Value for Alka Seltzer Plus, Allegra, Allegra D, Benadryl, Claritin, Claritin D, Mucinex, Mucinex DM, Zyrtec, Private Label, and Others......178
Table 169: Market Shares of Leading Cold, Allergy and Sinus Remedy (Tablet, Packet) Manufacturers by Value Sales through Drug Stores, Food Stores, Mass Merchandisers (including Wal-Mart) in the US (2015) - Percentage Breakdown for Chattem Chemicals, Inc., McNeil Consumer Healthcare, Merck & Co., Inc., RB plc, Private Label, and Others......179
Table 170: Market Shares of Leading Cough Drop Manufacturers through Supermarkets, Drug Stores, Mass Merchandisers (Including Wal-Mart), Gas and Convenience Stores, Military Commissaries and Select Dollar and Club Chains in the US (2015) - Percentage Breakdown by Value for Mondelez International, Prestige Brands Holdings, Inc. (Luden's), Reckitt Benckser, Inc. (Cepacol), Ricola, Inc., Private Label, and Others......180
Table 171: Market Shares of Leading Cough Syrup Manufacturers through Drug Store in the US (2015) - Percentage Breakdown by Value for Novartis AG, Pfizer, Inc., Procter & Gamble Co., ReckittBenckiser, Inc., and Others......181
Table 172: Market Shares of Leading Cough Syrup Manufacturers through Food Stores in the US (2015) - Percentage Breakdown by Value for Honey Naturals LLC, Pfizer, Inc., Prestige Brands Holdings, Inc., Procter and Gamble Co., Reckitt Benckiser, Inc., Private Label, and Others......182
Table 173: Market Shares of Leading Cough and Sore Throat Drop Manufacturers through Drug Stores in the US (2015) - Percentage Breakdown by Value for Kraft Heinz Company, Prestige Brands Holdings, Inc., Reckitt Benckiser, Inc., Ricola, Inc., Private Label, and Others......183
Table 174: Market Shares of Leading Cough and Cold Remedies Manufacturers for Over-the-Counter (OTC) Sector in the US (2015) - Percentage Breakdown by Value for Johnson & Johnson Private Limited, Merck & Co., Inc., Prestige Brands Holdings, Inc., Reckitt Benckiser Group Plc., Sanofi S.A., Private-Label and Others......184
Table 175: Market Shares of Leading Cough/Cold Remedy Producers by Value Sales in the US OTC Market (2014) - Percentage Breakdown for Johnson & Johnson, Merck & Co., Inc., Prestige Brands Holdings, Inc., Reckitt Benckiser plc., Sanofi S.A. Private Label, and Others......185
Consumer Health Products......186
Table 176: Market Shares of Leading Healthcare Products Manufacturers Worldwide (2015) - Percentage Share Breakdown by Value for Ecolab, Inc. and Others......186
Table 177: Market Shares of Leading Consumer Health Products Manufacturers in Indonesia (2015) - Percentage Share Breakdown by Value for Kalbe Farma Tbk PT, SOHO Group, Tempo Scan Pacific Tbk PT and Others......187
Table 178: Market Shares of Leading Consumer Health Product Producers by Value Sales in the US (2014) - Percentage Breakdown for Bayer AG, General Nutrition Centres, Inc., Glanbia Plc, GlaxoSmithKline Plc, Herbalife Ltd., Johnson & Johnson, Inc., Living Essentials, LLC, Merck & Co, Inc., NBTY, Inc., Novartis AG, Otsuka Holdings Co., Ltd., Pfizer, Inc., Prestige Brands Holdings, Inc., Procter & Gamble Co., Reckitt Benckiser Plc, Sanofi SA, Private Label, and Others......188
Table 179: Market Shares of Leading Consumer Health Product Producers by Value Sales in the US OTC Market (2014) - Percentage Breakdown for Bayer AG, GlaxoSmithKline Plc., Johnson & Johnson Inc., Merck & Co Inc., Novartis AG, Pfizer Inc., Prestige Brands Holdings Inc., Procter & Gamble Co., Reckitt Benckiser Plc., Sanofi S.A., Private Label and Others......189
Table 180: Market Shares of Leading Consumer Health Product Manufacturers in US (2015) - Percentage Breakdown by Value for Bayer AG, Johnson & Johnson Inc, Living Essentials, Merck & Co., Inc., NBTY, Inc., Novartis AG, Pfizer Inc, Procter & Gamble Co., Private-Label and Others......190
Vitamins......191
Table 181: Market Shares of Leading Vitamins Producers Worldwide (2015) - Percentage Share Breakdown by Value for Adisseo, BASF, DSM and Others......191
Table 182: Market Shares of Leading Vitamins Suppliers Worldwide (2015) - Percentage Breakdown by Value for Adisseo, BASF SE, Koninklijke DSM N.V., and Others......192
Table 183: Market Shares of Leading Vitamin Manufacturers through Supermarkets, Drug Stores and Mass Merchandisers (excluding Wal-Mart) in the US (2015) - Percentage Breakdown by Value for Bausch & Lomb, Inc., Bayer AG, Church & Dwight Co., Inc., Pfizer, Inc., Reckitt Benckiser Group plc, and Others......193
Table 184: Market Shares of Leading Vitamins Producers in the US (2015) - Percentage Share Breakdown by Value for Church & Dwight Co., Inc., and Others......194
Table 185: Market Shares of Leading Vitamin and Supplement Retailers in the US (2015) - Percentage Breakdown by Value for General Nutrition Centers, Inc., The Vitamin Shoppe, Whole Foods Market IP. L.P., and Others......195
Table 186: Market Shares of Leading Vitamins & Dietary Supplement Product Producers by Value Sales in the US (2014) - Percentage Breakdown for Bayer AG, General Nutrition Centres, Inc., GlaxoSmithKline Plc, Herbalife Ltd., Johnson & Johnson, Inc., Living Essentials, LLC, NBTY, Inc., Novartis AG, Otsuka Holdings Co., Ltd., Pfizer, Inc., Procter & Gamble Co., Private Label and Others......196
Vitamins (1 & 2 Letter)......197
Table 187: Market Shares of Leading Vitamin (1 & 2 Letter) Manufacturers through Drug Stores, Food Stores, Mass Merchandisers (including Wal-Mart) in the US (2015) - Percentage Breakdown by Value for Church & Dwight Co. Inc., NBTY, Inc., Pharmavite, LLC, Rexall Sundown, Inc., Private Label, and Others......197
Table 188: Market Shares of Leading Vitamin (1 & 2 Letter) Manufacturers through Supermarkets, Drug Stores and Mass Merchandisers (excluding Wal-Mart) in the US (2015) - Percentage Breakdown by Value for NBTY, Inc., Pharmative, LLC, Rexall Sundown, Inc., Private Label, and Others......198
Table 189: Market Shares of Leading Vitamin (1 & 2 Letter) Manufacturers through Supermarkets, Drug Stores, and Mass Merchandisers in the US (2015) - Percentage Breakdown by Value for Church & Dwight Co. Inc., NBTY, Inc., Pharmavite, LLC, Rexall Sundown, Inc., Private Label, and Others......199
Table 190: Market Shares of Leading Vitamin (1 & 2 Letter) Brands through Supermarkets, Drug Stores and Mass Merchandisers (excluding Wal-Mart) in the US (2015) - Percentage Breakdown by Value for Nature Made, Nature’s Bounty, Sundown Naturals, Private Label, and Others......200
Adult Gummy Vitamins......201
Table 191: Market Shares of Leading Adult Gummy Vitamin Brands through Food Stores, Drug Stores and Mass Merchandisers (excluding Wal-Mart) in the US (2015) - Percentage Breakdown by Value for One-A-Day(Bayer), Vitafusion, Private Label, and Others......201
Liquid Vitamins......202
Table 192: Market Shares of Leading Liquid Vitamin & Mineral Brands Through Drug Store in the US (2015) - Percentage Breakdown by Value for Alacer Emergen-C, Emergen-C, Joint Juice, Private Label, and Others......202
Table 193: Market Shares of Leading Liquid Vitamin & Mineral Manufacturers through Supermarkets, Drug Stores, and Mass Merchandisers in the US (2015) - Percentage Breakdown by Value for Alacer Corporation, Mead Johnson & Co., LLC, Neurobrands, LLC, Premier Nutrition Corporation, Private Label, and Others......203
Table 194: Market Shares of Leading Liquid Vitamin/Mineral Manufacturers through Drug Stores, Food Stores, Mass Merchandisers (including Wal-Mart) in the US (2015) - Percentage Breakdown by Value for Alacer Corporation, Mead Johnson & Co., LLC, Neurobrands, LLC, Private Label, and Others......204
Multivitamins......205
Table 195: Market Shares of Leading Multivitamin Brands through Supermarkets, Drug Stores and Mass Merchandisers (excluding Wal-Mart) in the US (2015) - Percentage Breakdown by Value for Airborne, Centrum, Centrum Silver, Flintstones, Private Label, and Others......205
Table 196: Market Shares of Leading Multivitamin Brands through Supermarkets, Drug Stores, Mass Merchandisers (including Wal-Mart) Military Commissaries and Select Dollar and Club Chains in the US (2015) - Percentage Breakdown by Value for Airborne, Bausch and Lomb PreserVision, Centrum Silver, One A Day VitaCraves, Private Label, and Others......206
Table 197: Market Shares of Leading Multivitamin Manufacturers by Value Sales through Drug Stores, Food Stores, Mass Merchandisers (including Wal-Mart) in the US (2015) - Percentage Share Breakdown for Bausch & Lomb, Inc., Bayer AG, Church & Dwight Co., Inc., Pfizer, Inc., Pharmative, LLC, Reckitt Benckiser Group plc, Private Label, and Others......207
Table 198: Market Shares of Leading Multivitamin Manufacturers through Supermarkets, Drug Stores, and Mass Merchandisers in the US (2015) - Percentage Breakdown by Value for Airborne (Reckitt Benckiser Group plc), Bausch & Lomb Inc., Bayer AG, Church & Dwight Co., Inc., Nature’s Way Products, LLC, Pfizer, Inc., Private Label, and Others......208
Vaccines......209
Table 199: Market Shares of Leading Vaccine Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for GlaxoSmithKline Plc (GSK), Merck & Co., Inc., Novartis International AG, Pfizer, Inc., Sanofi S.A., and Others......209
Diphtheria and Tetanus Vaccines......210
Table 200: Market Shares of Leading Diphtheria and Tetanus Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Infanrix), and Others......210
Hepatitis A Vaccines......211
Table 201: Market Shares of Leading Hepatitis A Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Havrix), and Others......211
Hepatitis B (Recombinant) Vaccines......212
Table 202: Market Shares of Leading Hepatitis B (Recombinant) Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for Engerix (GlaxoSmithKline Plc), and Others......212
Hepatitis A and Typhoid Polysaccharide Vaccines......213
Table 203: Market Shares of Leading Hepatitis A and Typhoid Polysaccharide Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Hepatyrix), and Others......213
Human Papillomavirus Vaccines......214
Table 204: Market Shares of Leading Human Papillomavirus Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Cervarix), and Others......214
Human Rotavirus Vaccines......215
Table 205: Market Shares of Leading Human Rotavirus Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Rotarix), and Others......215
Influenza Vaccines......216
Table 206: Market Shares of Leading Influenza Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Fluarix), and Others......216
Measles, Mumps and Rubella Vaccines......217
Table 207: Market Shares of Leading Measles, Mumps and Rubella Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Priorix), and Others......217
Tetanus Toxoid, reduced Diphthera Vaccines......218
Table 208: Market Shares of Leading Tetanus Toxoid, reduced Diphthera Vaccine Manufacturers in India (2014) - Percentage Breakdown by Value Sales for GlaxoSmithKline Plc (Boostrix), and Others......218
Typhoid Vaccines......219
Table 209: Market Shares of Leading Typhoid Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Typherix), and Others......219
Varilrix Vaccines......220
Table 210: Market Shares of Leading Varilrix Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Varilrix), and Others......220
Animal Healthcare......221
Table 211: Market Shares of Leading Animal Healthcare Companies by Value Sales Worldwide (2015) - Percentage Breakdown for Bayer AG, C.H. Boehringer Sohn AG & Ko., Eli Lilly and Company, Merck & Co., Inc., Merial, Zoetis, Inc., and Others......221
Table 212: Market Shares of Leading Animal Healthcare Companies by Value Sales in Brazil (2015) - Percentage Breakdown for Merck & Co., Inc., Merial, Ourofino, Vallée, Zoetis, Inc., and Others......222
Pet Health Products......223
Table 213: Market Shares of Leading Pet Health Product Manufacturers in the US (2015) - Percentage Breakdown by Value for Bayer AG, Merial Ltd., Pfizer Ltd., and Others......223
Table 214: Market Shares of Leading Clinical Research Organization (CRO) Companies Worldwide (2014) - Percentage Breakdown by Value Sales for Charles River Laboratories International, Inc., Covance, Inc., ICON Plc, INC Research, Inventiv Health, Inc., Laboratory Corporation of America Holdings, PAREXEL International, Pharmaceutical Product Development LLC, PRA International, Quest Diagnostics, Inc., Quintiles Transnational Holdings, Inc., Wuxi Pharmatech (Cayman) Inc., and Others......224
Artemisinin-based Combination Therapies (ACT)......225
Table 215: Market Shares of Leading Artemisinin-based Combination Therapies (ACT) Manufacturers by Value Sales Worldwide (2015) - Percentage Breakdown for Ajanta Pharma Limited, Cipla Limited, Guilin Pharmaceutical Co., Ltd., Ipca Laboratories, Novartis AG, Quality Pharma Products Pvt Ltd., Sanofi S.A., and Sigma Pharmaceuticals Limited......225
Bone Disease Therapeutics......226
Table 216: Market Shares of Leading Bone Diseases Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for Amgen, Inc., Eli Lilly and Company, GlaxoSmithKline Plc, Merck Ltd., Novartis AG, Pfizer, Inc., F. Hoffmann-La Roche AG, Sanofi S.A., and Others......226
Epilepsy Therapeutics......227
Table 217: Market Shares of Leading Epilepsy Medicine Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for GlaxoSmithKline Plc, Johnson & Johnson, Novartis AG, Pfizer, Inc., Sanofi S.A., and Others......227
Insomnia Drugs......228
Table 218: Market Shares of Leading Insomnia Drugs Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Jazz Pharmaceuticals (JAZZ), Sanofi S.A. (SNY), Somaxon Pharmaceuticals, Inc. (SOMX), Takeda Pharmaceutical Company Limited, Generics, and Others......228
Cardio-Cerebral Vascular (CCV) Drugs......229
Table 219: Market Shares of Leading Cardio-Cerebral Vascular (CCV) Drugs Manufacturers in China (2015) - Percentage Share Breakdown by Value for Sihuan Pharmaceutical Holdings Group Ltd., Sanofi S.A., Qilu pharmaceutical Co., Ltd. and Others......229
Injectables......230
Table 220: Market Shares of Leading Injectable Manufacturers by Value Sales in France (2014) - Percentage Breakdown for Aguettant Limited, Baxter International, Inc., B. Braun Melsungen AG, F. Hoffmann-La Roche Ltd., Lake Forest Park Medical Clinic (LFP), Mylan Laboratories, Inc., Novartis International AG (Sandoz), Laboratoires PANPHARMA S.A., Sanofi S.A., and Others......230
Table 221: Market Shares of Leading Injectable Manufacturers by Value Sales in Germany (2014) - Percentage Breakdown for AstraZeneca Plc, Baxter International, Inc., Fresenius SE & Co., Medac GmbH, Novartis International AG (Sandoz), Sanofi S.A.,Teva Pharmaceutical Industries Ltd. and Others......231
Table 222: Market Shares of Leading Injectable Manufacturers by Value Sales in Italy (2014) - Percentage Breakdown for F. Hoffmann-La Roche Ltd., Hospira, Inc., Johnson & Johnson, KEDRION GROUP S.p.A., Novartis International AG (Sandoz), Pfizer, Inc., Sanofi S.A., Teva Pharmaceutical Industries Ltd. and Others......232
Table 223: Market Shares of Leading Injectable Manufacturers by Value Sales in Spain (2014) - Percentage Breakdown for F. Hoffmann-La Roche Ltd., Ges Genericos Españoles Laboratorio S.A., Grifols, S.A, Hospira, Inc., Johnson & Johnson, Normon S.A., Sanofi S.A., Teva Pharmaceutical Industries Ltd., and Others......233
Table 224: Market Shares of Leading Injectable Manufacturers by Value Sales in the UK (2014) - Percentage Breakdown for Actavis Plc (Watson), AstraZeneca Plc, Baxter International, Inc., Fresenius SE & Co., Hospira, Inc., Sanofi S.A., Teva Pharmaceutical Industries Ltd., and Others......234
Table 225: Sanofi-Aventis’s Sales by Geographic Region Worldwide (2013) in Percentage for United States, Emerging Markets, Western Europe and Rest of the World......235
Table 226: Sanofi-Aventis’s Sales by Product Segment Worldwide (2013) in Percentage for Pharmaceuticals, Vaccines, and Animal Health......236
Table 227: Sanofi S.A.’s Sales by Business Segment (2015) - Percentage Share Breakdown by Value for Active Pharmaceutical Ingredients and Formulations......237
Table 228: Sanofi S.A.’s Sales by Division (2015) - Percentage Share Breakdown by Value for Animal Healthcare (AHC), Pharmaceuticals and Vaccines......238